Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TAAR8A Activators

TAAR8A activators represent a chemical class of compounds that interact with the trace amine-associated receptor 8A, a G protein-coupled receptor (GPCR). This receptor, like others in the TAAR family, is believed to respond to small molecule ligands, traditionally amines, and to engage in signaling cascades that regulate various physiological processes. The activation of TAAR8A involves the binding of an agonist to the receptor, which triggers a conformational change, allowing the receptor to couple with intracellular G proteins. This coupling initiates a signaling cascade, often resulting in the production of second messengers such as cyclic AMP (cAMP), which further propagates the signal within the cell.

The class of TAAR8A activators includes compounds that are capable of increasing the receptor's activity either directly or by influencing related cellular mechanisms. For instance, certain activators may increase intracellular cAMP levels, either by stimulating adenylate cyclase or by inhibiting the breakdown of cAMP via phosphodiesterases, which in turn can enhance the receptor's signaling. Other members of this class can modulate the activity of TAAR8A by altering the levels or activity of neurotransmitters that affect GPCR signaling pathways. Additionally, some compounds can influence the receptor indirectly by altering the signaling environment in which TAAR8A operates, such as by affecting other GPCRs that may have crosstalk with TAAR8A. Activation of TAAR8A by these activators influences intracellular signaling pathways and can modify cellular responses, making the understanding of these compounds and their interactions with TAAR8A an area of interest in the study of GPCR signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Inhibits phosphodiesterases, preventing cAMP breakdown, thus sustaining GPCR signaling that could possibly activate TAAR8A via cAMP-dependent pathways.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

As a neurotransmitter and hormone, it can modulate GPCR function and could possibly activate TAAR8A through interactions with sympathetic nervous system pathways.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Acts on its own GPCRs but also modulates other GPCR signaling; could possibly activate TAAR8A through histaminergic pathway interactions.

Levodopa

59-92-7sc-205372
sc-205372A
5 g
25 g
$54.00
$171.00
9
(1)

As a precursor to dopamine, it can increase dopamine levels, which could possibly activate TAAR8A via altered neurotransmission.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

An adenosine receptor antagonist that increases cAMP by preventing the inhibitory effect of adenosine on adenylate cyclase, potentially affecting TAAR8A signaling through cAMP-dependent pathways.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

A selective inhibitor of phosphodiesterase 4 that raises cAMP levels in the central nervous system, which could possibly activate TAAR8A if linked to cAMP pathways.